Protective Effects of (-)-Butaclamol Against Gentamicin-Induced Ototoxicity: In Vivo and In Vitro Approaches
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094201 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sumin Hong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Ansan Hospital, Ansan-si 15355, Republic of Korea. Hauptthemen laut MEDLINE: Gentamicins, Ototoxicity, Protective Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Korea University Grants, Basic Science Research Program through the National Research Foundation of Korea, the Korea Environment Industry & Technology Institute (KEITI) through the Technology Devel-opment Project for Safety Management of Household Chemical Products,….
Abstract (Originalsprache)
Gentamicin-induced ototoxicity leads to irreversible sensorineural hearing loss due to structural and functional damage to inner ear hair cells. In this study, we identified (-)-butaclamol as a potent protective agent against gentamicin-induced cytotoxicity through high-content screening (HCS) of a natural compound library. (-)-Butaclamol significantly enhanced cell viability in both HEI-OC1 cells and zebrafish neuromasts, demonstrating robust protection against gentamicin toxicity. Mechanistically, (-)-butaclamol inhibited intrinsic apoptosis, as evidenced by reduced TUNEL-positive cell counts and the downregulation of BAX and caspase-3, alongside the upregulation of BCL-2. Moreover, (-)-butaclamol activated key survival signaling pathways, including AKT/mTOR and ERK, while suppressing the inflammatory regulator NF-κB. Additional analyses revealed that (-)-butaclamol effectively mitigated oxidative stress and restored autophagic activity, as confirmed by CellROX and LysoTracker assays. Notably, TMRE staining showed that (-)-butaclamol preserved mitochondrial membrane potential in zebrafish hair cells, indicating mitochondrial protection. Collectively, these findings suggest that (-)-butaclamol exerts comprehensive cytoprotective effects against gentamicin-induced ototoxicity by modulating apoptosis, enhancing survival signaling, and restoring mitochondrial and cellular homeostasis. These results highlight the therapeutic potential of (-)-butaclamol and provide a foundation for future studies aimed at its clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Ansan Hospital, Ansan-si 15355, Republic of Korea.
- Laboratory of Otorhinolaryngology-Head & Neck Surgery, Graduate School of Medicine, Korea University, Seoul 02841, Republic of Korea.
- Biomedical Research Center, Korea University College of Medicine, Ansan Hospital, Ansan-si 15355, Republic of Korea.
- Zebrafish Translational Medical Research Center, Korea University, Seoul 02841, Republic of Korea.
- Rare and Intractable Disease Research Group, Korea University, Ansan Hospital, Ansan-si 15355, Republic of Korea.
ORCID-Profile: Kyungtae Hyun, June Choi
Förderung
- the Korea University Grants
- Basic Science Research Program through the National Research Foundation of Korea
- the Korea Environment Industry & Technology Institute (KEITI) through the Technology Devel-opment Project for Safety Management of Household Chemical Products,…
- Ansan-Si hidden champion fostering and supporting project funded by Ansan city
- the Korea Medical Device Development Fund funded by the Korean government (Ministry of Science and ICT, Industry and Energy, Health & Welfare, and Food and Dru…
- Korea University Grants
- Basic Science Research Program
- Korea Environment Industry & Technology Institute (KEITI)
Zitieren
APA
Hong, S., Han, E., Park, S., Hyun, K., Lee, Y., Baek, H. W., Kim, H. J., Rah, Y. C., & Choi, J. (2025). Protective Effects of (-)-Butaclamol Against Gentamicin-Induced Ototoxicity: In Vivo and In Vitro Approaches. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094201
Vancouver
Hong S, Han E, Park S, Hyun K, Lee Y, Baek HW, et al. Protective Effects of (-)-Butaclamol Against Gentamicin-Induced Ototoxicity: In Vivo and In Vitro Approaches. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094201
BibTeX
@article{Hong2025,
author = {Hong, Sumin and Han, Eunjung and Park, Saemi and Hyun, Kyungtae and Lee, Yunkyoung and Baek, Hyun Woo and Kim, Hwee-Jin and Rah, Yoon Chan and Choi, June},
title = {Protective Effects of (-)-Butaclamol Against Gentamicin-Induced Ototoxicity: In Vivo and In Vitro Approaches},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094201}
}
EUVIMED